Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Estrogen Use Alone Does Not Increase Breast Cancer Risk, JAMA Analysis Finds

This article was originally published in The Pink Sheet Daily

Executive Summary

Women’s Health Initiative data analysis shows increase in frequency of mammography screenings requiring short-term follow-up.

You may also be interested in...



Wyeth Modifies Premarin Warnings Slightly

Data from estrogen-alone and estrogen-plus-progestin substudies of the Women’s Health Initiative now included in black box for Premarin products.

Wyeth Modifies Premarin Warnings Slightly

Data from estrogen-alone and estrogen-plus-progestin substudies of the Women’s Health Initiative now included in black box for Premarin products.

Estrogen-Only Hormone Therapy May Offer Some Cardio-Protection

Wyeth plans discussions with FDA on results of follow-up to WHI Coronary Heart Disease study.

Topics

UsernamePublicRestriction

Register

PS063981

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel